Jennison Associates LLC Infla Rx N.V. Transaction History

Jennison Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 02, 2018	SELL	$27.33 - $41.46 $1.76 Million - $2.67 Million	-64,368 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$20.21 - $32.0 $2.79 Million - $4.41 Million	-137,938 Reduced 68.18%	64,368 $1.86 Million
Q4 2017 Jan 25, 2018	BUY	$14.55 - $23.99 $2.94 Million - $4.85 Million	202,306	202,306 $4.24 Million

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $114M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.